Advancing ADC Technology

Pioneering precision linkage technology for the next generation of Antibody-Drug Conjugates.

Partner With Us

Our Mission

GlycoBridge Biosciences Inc is dedicated to solving challenges in antibody drug conjugates. By leveraging novel glyco-engineering methods, we create homogeneous, stable, and highly effecitive antibody drug conjugates that bridge the gap between laboratory potential and clinical reality.

Key Publications on Our Technology

  • "Efficient Preparation of Homogenous Antibody Conjugates via Glycosite-Specific Transglycosylation Enabled by Readily Available Glycosyl Donors" Cai, D.; Zhao, Y.; Lu, G.; Li, C.; Lao, Y.; Mudududdla, R.; Zhang, J.; Jia, P.; Huang, P.; Wu, W.; Nguyen, T. T.; Huang, X.; Li, L.; Tang, W. Angew. Chem. Int. Ed. 2026. Link.

    • Contact Us

    Interested in our technology platform or partnership opportunities? Send us a message.